Cautious exuberance after the first quarter
Article Abstract:
The first quarter of 2004 (1Q04) registered high investor confidence as US biotech companies raised from $7.3 billion to $2.8 billion in the same quarter of 2003 and also the same in the last quarter of 2003. The increase in the investor confidence was because of nine other products approved by the US FDA, ImClone Systems' Erbitux.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
University entrepreneur initiatives on the rise
Article Abstract:
The University-based new entrepreneurial programs and projects are reshaping the graduate education of scientists and engineers. The programs offer certificates, master degrees, project work and networking opportunities both in the United States and Europe.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Advice for partnering with pharma
Article Abstract:
The changing attitudes of the world's largest pharmaceutical companies towards collaborating with biotech firms are discussed. Few guidelines are given for the new biotech companies that are interested in partnering with big pharmaceutical companies.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: How do you measure the customer experience? Coping with media fragmentation. Shopping rediscovered
- Abstracts: Beware of third parties bearing lawsuits. Quadropoly. Stoy story
- Abstracts: Factors explaining the inefficient valuation of intangibles. Intellectual capital and the capital market - organization and competence
- Abstracts: Clarke is big hit at PR Seminar. Press PR pros trade wish lists. Conventions/conf- planners
- Abstracts: How stable is the Internet? Get on the blog bandwagon. Time is ripe for digital video feeds off the web.